Patent details

EP1781276 Title: USE OF PEPTIDE COMPOUNDS FOR TREATING BONE CANCER PAIN, CHEMOTHERAPY- AND NUCLEOSIDE-INDUCED PAIN

Basic Information

Publication number:
EP1781276
PCT Application Number:
PCT/EP/2005/009067
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057773418
PCT Publication Number:
WO/2006/021412
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF PEPTIDE COMPOUNDS FOR TREATING BONE CANCER PAIN, CHEMOTHERAPY- AND NUCLEOSIDE-INDUCED PAIN
French Title of Invention:
UTILISATION DE COMPOSÉS PEPTIDIQUES POUR LE TRAITEMENT DE DOULEURS LIÉES AU CANCER DES OS ET DES DOULEURS INDUITES PAR LA CHIMIOTHÉRAPIE OU DES NUCLÉOSIDES
German Title of Invention:
VERWENDUNG VON PEPTIDVERBINDUNGEN ZUR BEHANDLUNG VON SCHMERZEN DURCH KNOCHENKREBS, CHEMOTHERAPIE- UND NUCLEOSID-BEDINGTEN SCHMERZEN
SPC Number:

Dates

Filing date:
22/08/2005
Grant date:
23/06/2010
EP Publication Date:
23/06/2010
PCT Publication Date:
02/03/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/05/2007
EP B1 Publication Date:
23/06/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/08/2010
Expiration date:
22/08/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/08/2005
 
 

Name:
UCB Pharma GmbH
Address:
Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

Inventor

1

Name:
BEYREUTHER Bettina
Address:
Germany (DE)

2

Name:
STÖHR Thomas
Address:
Germany (DE)

Priority

1

Priority Number:
604810 P
Priority Date:
27/08/2004
Priority Country:
United States (US)

2

Priority Number:
04020402
Priority Date:
27/08/2004
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
A61K 31/165;
Filing date Document type Number of pages